Alembic Pharmaceuticals gains as its arm set to acquire Utility Therapeutics
Alembic Pharmaceuticals is currently trading at Rs 1000.60, up by 10.95 points or 1.11% from its previous closing of Rs 989.65 on the BSE. The scrip opened at…
Alembic Pharmaceuticals is currently trading at Rs 1000.60, up by 10.95 points or 1.11% from its previous closing of Rs 989.65 on the BSE. The scrip opened at…
Alembic Pharmaceuticals is currently trading at Rs. 1078.25, up by 106.40 points or 10.95% from its previous closing of Rs. 971.85 on…
Alembic Pharmaceuticals is currently trading at Rs. 873.20, up by 5.75 points or 0.66% from its previous closing of Rs. 867.45 on…
Alembic Pharmaceuticals is currently trading at Rs. 1013.55, up by 8.70 points or 0.87% from its previous closing of Rs. 1004.85 on…
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for…
Alembic Pharmaceuticals is currently trading at Rs. 661.55, up by 49.35 points or 8.06% from its previous closing of Rs. 612.20 on…
Alembic Pharmaceuticals is currently trading at Rs. 735.70, up by 3.60 points or 0.49% from its previous closing of Rs. 732.10 on…